Silver Book Fact

Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.

MEDTAP International, Inc. The Value of Investment in Health Care: Better care, better lives. Bethesda, MD: MEDTAP; 2004. http://www.aha.org/content/00-10/08affordability-value.pdf

Reference

Title
The Value of Investment in Health Care: Better care, better lives
Publisher
MEDTAP
Publication Date
2004
Authors
MEDTAP International, Inc
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Pioglitazone associated with relative risk reduction in recurrent stroke
    The PROactive trial to manage glucose in diabetics with a history of cardiovascular disease, stroke, or other vascular risk factors found that treatment with pioglitazone was associated with a 47% relative…  
  • From 1979 to 2005, the number of cardiac catheterizations increased 342% to 1,322,000 annually.  
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.  
  • Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.  
  • Echocardiography and nuclear imaging are used for provocative “stress” testing of the heart. When combined with other forms of stress, both can identify the presence of coronary artery-obstructing lesions that…